These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37817441)

  • 1. The N-terminal peptide of the main protease of SARS-CoV-2, targeting dimer interface, inhibits its proteolytic activity.
    Song S; Kim Y; Kwak K; Lee H; Park H; Kim YB; Lee HJ; Kang LW
    BMB Rep; 2023 Nov; 56(11):606-611. PubMed ID: 37817441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large scale peptide screening against main protease of SARS CoV-2.
    Uddin MJ; Akhter H; Chowdhury U; Mawah J; Karim ST; Jomel M; Islam MS; Islam MR; Onin LAB; Ali MA; Efaz FM; Halim MA
    J Comput Chem; 2023 Mar; 44(8):887-901. PubMed ID: 36478400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantum biochemistry, molecular docking, and dynamics simulation revealed synthetic peptides induced conformational changes affecting the topology of the catalytic site of SARS-CoV-2 main protease.
    Amaral JL; Oliveira JTA; Lopes FES; Freitas CDT; Freire VN; Abreu LV; Souza PFN
    J Biomol Struct Dyn; 2022; 40(19):8925-8937. PubMed ID: 33949286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations.
    Tumskiy RS; Tumskaia AV; Klochkova IN; Richardson RJ
    Comput Biol Med; 2023 Feb; 153():106449. PubMed ID: 36586228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potent COVID-19 main protease inhibitors by loading of favipiravir on Mg
    Al-Shuaeeb RAA; Abd El-Mageed HR; Ahmed SA; Mohamed HS; Hamza ZS; Rafi MO; Rahman MS
    J Biomol Struct Dyn; 2023; 41(21):11437-11449. PubMed ID: 36591698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the mechanism of SARS-CoV-2 main protease autocatalytic maturation from model precursors.
    Aniana A; Nashed NT; Ghirlando R; Coates L; Kneller DW; Kovalevsky A; Louis JM
    Commun Biol; 2023 Nov; 6(1):1159. PubMed ID: 37957287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Biomol Struct Dyn; 2021 Aug; 39(12):4362-4374. PubMed ID: 32568613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depicting the inhibitory potential of polyphenols from
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Biomol Struct Dyn; 2022 Jun; 40(9):4110-4121. PubMed ID: 33292085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense.
    Ju X; Wang Z; Wang P; Ren W; Yu Y; Yu Y; Yuan B; Song J; Zhang X; Zhang Y; Xu C; Tian B; Shi Y; Zhang R; Ding Q
    mBio; 2023 Aug; 14(4):e0137323. PubMed ID: 37439567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of polyphenols from
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6747-6760. PubMed ID: 32762411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir.
    Paciaroni A; Libera V; Ripanti F; Orecchini A; Petrillo C; Francisci D; Schiaroli E; Sabbatini S; Gidari A; Bianconi E; Macchiarulo A; Hussain R; Silvestrini L; Moretti P; Belhaj N; Vercelli M; Roque Y; Mariani P; Comez L; Spinozzi F
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico discovery of novel inhibitors from Northern African natural products database against main protease (Mpro) of SARS-CoV-2.
    Byadi S; Oblak D; Kassmi Y; Sadik K; Hachim ME; Podlipnik Č; Aboulmouhajir A
    J Biomol Struct Dyn; 2023 Apr; 41(7):2900-2910. PubMed ID: 35168469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting SARS-CoV-2 Main Protease (MPro) with Kinase Inhibitors: A Promising Approach for Discovering Antiviral and Anti-inflammatory Molecules against SARS-CoV-2.
    Anton DB; Galvez Bulhões Pedreira J; Zvirtes ML; Laufer SA; Ducati RG; Goettert M; Saraiva Macedo Timmers LF
    J Chem Inf Model; 2023 Jul; 63(13):4138-4146. PubMed ID: 37329322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmasking the Conformational Stability and Inhibitor Binding to SARS-CoV-2 Main Protease Active Site Mutants and Miniprecursor.
    Kovalevsky A; Coates L; Kneller DW; Ghirlando R; Aniana A; Nashed NT; Louis JM
    J Mol Biol; 2022 Dec; 434(24):167876. PubMed ID: 36334779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral peptides inhibiting the main protease of SARS-CoV-2 investigated by computational screening and in vitro protease assay.
    Stewart J; Shawon J; Ali MA; Williams B; Shahinuzzaman ADA; Rupa SA; Al-Adhami T; Jia R; Bourque C; Faddis R; Stone K; Sufian MA; Islam R; McShan AC; Rahman KM; Halim MA
    J Pept Sci; 2024 Apr; 30(4):e3553. PubMed ID: 38031661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies.
    Gupta S; Singh AK; Kushwaha PP; Prajapati KS; Shuaib M; Senapati S; Kumar S
    J Biomol Struct Dyn; 2021 Aug; 39(12):4334-4345. PubMed ID: 32476576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery.
    Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK
    Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoprocessing and oxyanion loop reorganization upon GC373 and nirmatrelvir binding of monomeric SARS-CoV-2 main protease catalytic domain.
    Nashed NT; Kneller DW; Coates L; Ghirlando R; Aniana A; Kovalevsky A; Louis JM
    Commun Biol; 2022 Sep; 5(1):976. PubMed ID: 36114420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimization of expression conditions and determination the proteolytic activity of codon-optimized SARS-CoV-2 main protease in Escherichia coli].
    Chen Y; Fu Z; Yan G; Lin Y; Liu X
    Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1334-1345. PubMed ID: 33973446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of dimerization and N3 binding on molecular dynamics of SARS-CoV and SARS-CoV-2 main proteases.
    Tekpinar M; Yildirim A
    J Biomol Struct Dyn; 2022 Sep; 40(14):6243-6254. PubMed ID: 33525993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.